Barclays analyst Balaji Prasad downgraded Viatris to Underweight from Equal Weight with an unchanged price target of $11. The analyst sees a “show-me” narrative for the company, saying investors need to be convinced about the growth potential of future specialty builds. It could be a couple of quarters for the stock to reach an inflection, the analyst tells investors in a research note. The firm expects Viatris’ “drawn-out transformation journey” to impede its share performance.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on VTRS:
- Viatris Reports Strong Financial and Operational Results for First Quarter 2023 and Reaffirms Full-Year 2023 Guidance Ranges[1]
- VTRS Earnings this Week: How Will it Perform?
- Viatris downgraded to Equal Weight on near-term uncertainty at Barclays
- Viatris downgraded to Equal Weight from Overweight at Barclays